| scholarly article | Q13442814 |
| P2093 | author name string | Wei Xie | |
| Lan Ma | |||
| Yan Zhang | |||
| Yu Cui | |||
| Chao Wang | |||
| Yonghui Wu | |||
| Shengyuan Wang | |||
| Qunhong Wu | |||
| Jinfeng Zhu | |||
| Decai Wang | |||
| Rui Dang | |||
| Yu Cu | |||
| P2860 | cites work | Phospholipids and sports performance | Q21245422 |
| Alzheimer's Disease | Q22248111 | ||
| Forecasting the global burden of Alzheimer’s disease | Q22252403 | ||
| Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease | Q27012950 | ||
| A possible role for lutein and zeaxanthin in cognitive function in the elderly | Q27027011 | ||
| Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase | Q28188098 | ||
| Analysis of variance of repeated data measured by water maze with SPSS | Q31091042 | ||
| A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease | Q33621285 | ||
| The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial. | Q50611706 | ||
| Altered synapses and gliotransmission in Alzheimer's disease and AD model mice. | Q51020529 | ||
| AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet | Q72577338 | ||
| Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomised trials | Q73840977 | ||
| A triphenylene based zinc ensemble as an oxidation inhibitor | Q83505698 | ||
| Epigenetic mechanisms in Alzheimer's disease | Q83829640 | ||
| Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains | Q85246354 | ||
| Oxidative stress in the progression of Alzheimer disease in the frontal cortex | Q33680790 | ||
| Targeting Abeta and tau in Alzheimer's disease, an early interim report | Q33829008 | ||
| Antioxidant therapy in Alzheimer's disease: theory and practice | Q34066474 | ||
| Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial | Q34096620 | ||
| Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline | Q34113201 | ||
| Reduced Alzheimer's disease pathology by St. John's Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice. | Q34380018 | ||
| Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial | Q34490891 | ||
| The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis" | Q34572079 | ||
| Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment | Q34652047 | ||
| The effects of IQPLUS Focus on cognitive function, mood and endocrine response before and following acute exercise | Q35533484 | ||
| Diet rich in date palm fruits improves memory, learning and reduces beta amyloid in transgenic mouse model of Alzheimer's disease | Q35792238 | ||
| Acetylcholinesterase and its inhibition in Alzheimer disease | Q35800622 | ||
| Behavioural changes and psychological symptoms in dementia disorders | Q36292518 | ||
| A century of Alzheimer's disease | Q36643414 | ||
| The role of eicosanoids in the brain. | Q37093316 | ||
| Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression | Q37111515 | ||
| Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease. | Q37294285 | ||
| Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment | Q37450188 | ||
| Oxidative stress in diabetes and Alzheimer's disease | Q37455830 | ||
| Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology | Q37620751 | ||
| Can nutrients prevent or delay onset of Alzheimer's disease? | Q37698047 | ||
| Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies | Q37703325 | ||
| Amyloid-independent mechanisms in Alzheimer's disease pathogenesis | Q37808579 | ||
| Berberine: a potential multipotent natural product to combat Alzheimer's disease. | Q37914665 | ||
| An old test for new neurons: refining the Morris water maze to study the functional relevance of adult hippocampal neurogenesis | Q38105063 | ||
| Web-based application to project the burden of Alzheimer's disease | Q38443522 | ||
| Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers | Q39182204 | ||
| Hippocampal long-term depression mediates spatial reversal learning in the Morris water maze. | Q45265257 | ||
| Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice. | Q45996088 | ||
| Effect of dietary supplementation of dates in Alzheimer's disease APPsw/2576 transgenic mice on oxidative stress and antioxidant status | Q46875913 | ||
| Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. | Q48306292 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | e0143135 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Protective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's Disease | |
| P478 | volume | 10 |
Search more.